A lab study demonstrated that CPC (CetylPyridinium Chloride) was highly effective against a human coronavirus (BioRxiv 2020
, BioRxiv 2020
). CPC mouthwash is also part of the FLCCC I-MASK+
protocol for the prevention and treatment of COVID-19.
A scientific review, published in the Journal of Formosan Medical Association
(October 2021) also concluded that mouthwash containing CPC shows potential for reducing the viral load of COVID-19 virus in the throat.
Instruction: twice a day or after having been out for prevention, and three times a day for early treatment of COVID-19.
What is Cetylpyridinium Chloride (CPC) Made Of?
Cetylpyridinium chloride (CPC) is obtained by quaternization of pyridine with cetyl chloride
What Does Cetylpyridinium Chloride Do in Mouthwash?
CPC functions by penetrating the cell membrane. This causes cell components to leak, which eventually leads to cell death. It is a well-known antimicrobial agent used in mouthwash to promote gingival health. It has also been used as an antiseptic when treating infections in the mouth and throat.
Cetylpyridinium Chloride Dangers
Cetylpyridinium chloride in mouthwash has been misattributed as a cause of oral cancer in the past, but research has not shown it to link to any form of cancer – no more than any other compound used in mouthwash. The risks of CPC are minor; it is only toxic in large doses (1 gram or more of pure CPC, ingested) and as an antimicrobial spray on food, it is far more helpful than harmful.
Frequent and heavy use of a CPC-based mouthwash or toothpaste can bring side effects, however. Frequent use of CPC-based oral hygiene products can cause minor brown staining on teeth, a slight burning sensation in the gums and the products have been found to promote the formation of calculus (also known as tartar) on some users' teeth. None of these side effects are particularly harmful, but they should be considered.
Best Cetylpyridinium Chloride Mouthwash Brands 2023
1. Colgate Total Pro-Shield Alcohol Free Mouthwash
Cetylpyridinium Chloride (0.075%). Purpose: Antigingivitis/Antiplaque. Inactive Ingredients: Water, Glycerin, Propylene Glycol, Sorbitol, Poloxamer 407, Flavor, Potassium Sorbate, Citric Acid, Sodium Saccharin, FD&C Blue No. 1.
- Antibacterial Mouthwash Provides 12-Hour Protection Against Germs After Eating and Drinking
- Kills 99% of Germs on Contact
- Significantly Reduces Plaque
- Helps Prevent Gingivitis
- Alcohol Free Mouthwash
- No Burn of Alcohol (Does Not Contain Ethanol)
2. Crest Scope Outlast Mouthwash
Crest Scope Mouthwash Ingredients
Water, alcohol (12.25 wt%), glycerin, polysorbate 80, flavor, sodium saccharin, sodium benzoate, cetylpyridinium chloride, benzoic acid, blue 1.
- Keeps breath feeling fresh up to 5x longer vs. brushing alone
- Speak confidently with the #1 fresh breath brand among non-drug mouthwashes
- P&G Calculation based on Nielsen US reported sales for year ending w/o 1/10/2015
- Crest clean meets Scope freshness
- Kills 99% of bad breath germs in lab tests
- Made in the USAwith U.S. and imported ingredients
3. Colgate Zero with CPC
The biggest red flag on an ingredient list for mouthwash is alcohol, according to board-certified dentist Michaela Tozzi
, DMD, since it can irritate the gums and oral tissue. Plus, it temporarily depletes saliva flow, which acts as the mouth's immune system. Colgate Zero is alcohol free and contains the anti-viral CPC.
Gargle twice a day or after having been out for prevention, and three times a day for early treatment of COVID-19.
- Active Ingredient: Cetylpyridinium Chloride
- Kills 99% of plaque germs
- 0% alcohol
- 0% dyes
- 0% artificial flavors
- 0% artificial sweeteners
4. ACT Dry Mouth Anticavity Mouthwash
Water, Sorbitol, Poloxamer 407, Propylene Glycol, Menthol, Methyl Salicylate, Sodium Phosphate, Disodium Phosphate, Potassium Sorbate, Polysorbate 20, Sodium Saccharin, Flavor, Cetylpyridinium Chloride, Caldium Disodium Edta, Sodium Benzoate, Green 3, Yellow 5 (309-039)
- Contains one (1) 18 fluid ounce bottle of ACT Anticavity Zero Alcohol Fluoride Mouthwash Mint Flavor
- ZERO ALCOHOL: This ACT Oral Care Product is an alcohol-free mouthwash
- 3 BENEFITS IN 1: This fluoride mouthwash is designed to help prevent cavities, strengthen teeth and freshen breath
- ACCURATE DOSING CUP: Get the right dose of fluoride with the easy-to-use dosing meter
- DENTIST RECOMMENDED BRAND: ACT Fluoride Mouthwash is the #1 dentist recommended fluoride brand*
- FOR AGES 6 & UP: ACT Fluoride Mouthwash is for adults and kids ages 6 and up
5. Crest Pro Health Intense Mouthwash with CPC - Cetylpyridinium Chloride Mouthwash
Cetylpyridinium Chloride 0.05% Inactive Ingredients Water, Alcohol (15 Wt%), Propylene Glycol, Flavor, Poloxamer 407, Sucralose, Benzoic Acid, Sodium Benzoate, Blue 1, Yellow 6
- 99% Germ Kill with no medicinal taste
- Cooling sensation
- Keeps teeth clean longer
- Freshens breath
- Fights plaque & gingivitis
6. Scope Mouthwash
Cetylpyridinium Chloride (CPC), Water, Alcohol (15 Wt%), Glycerin, Flavor, Polysorbate 80, Sodium Saccharin, Sodium Benzoate, Benzoic Acid, Blue 1, Yellow 5
- Kills 99% of bad breath germs in lab tests
- Crest clean meets Scope freshness
- Cosmetic mouthwash
- Made in the USA with U.S. and imported ingredients
- Original Mint FlavorBuy on Amazon
Virucidal activity of CPC-containing oral rinses against SARS-CoV-2 variants and are active in the presence of human saliva
A team of international scientists has demonstrated the usefulness of cetylpyridinium chloride-containing mouthwashes in inhibiting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and reducing the risk of viral transmission. The study is currently available on the bioRxiv* preprint server.
Due to the presence of angiotensin-converting enzyme 2 (ACE2) in the oral gingival epithelium and salivary glands, the human oral cavity may act as a reservoir for SARS-CoV-2. The ACE2 present on the host cell membrane acts as the primary entry receptor for SARS-CoV-2. Evidence indicates that the saliva of SARS-CoV-2-infected individuals contains high amounts of viral RNA and that aerosols formed from the saliva can act as a potential vector for viral transmission.
Several health organizations have advised using mouthwashes during dentistry procedures as a measure to inhibit SARS-CoV-2 transmission. Bioactive ingredients present in mouthwashes, including dequalinium chloride, benzalkonium chloride, cetylpyridinium chloride (CPC) and chlorhexidine, have been found to inhibit pathogens by charge-mediated attraction and destabilization of the lipid envelope.
In the current study, the scientists have investigated in vitro antiviral efficacy of mouthwashes containing cetylpyridinium chloride (0.07%) or chlorhexidine digluconate (0.2%) against SARS-CoV-2 and its variants, including B.1.1.7, B.1.351, and P1. Moreover, in a separate set of in vitro experiments, they have determined the antiviral efficacy of cetylpyridinium chloride-containing mouthwash in the presence of human saliva to investigate whether salivary components can deactivate the active agent.
To measure viral titers, they conducted a plaque assay after 30 seconds of mouthwash exposure. They tested different mouthwash formulations including cetylpyridinium chloride with flavor, cetylpyridinium chloride with flavor and herbal mix, and chlorhexidine digluconate with flavor. As positive and negative controls, they have used 70% ethanol and water, respectively.
The plaque assay findings revealed that both formulations of cetylpyridinium chloride-containing mouthwash are capable of inhibiting SARS-CoV-2 by 99.99%. After 30 seconds of exposure to these formulations resulted in a viral titer value below the detection limit. In contrast, chlorhexidine digluconate-containing mouthwash showed significantly lower efficacy in inhibiting SARS-CoV-2.
Furthermore, both formulations of cetylpyridinium chloride-containing mouthwash exhibited high efficacy in reducing the titers of B.1.1.7, B.1.351, and P1 below the detection limit. However, no such reduction was observed for chlorhexidine digluconate-containing mouthwash.
Functionality of mouthwash in presence of human saliva
Scientists first tested whether mouthwash formulations remain effective in the presence of saliva by testing the endogenous antiviral efficacy of saliva against SARS-CoV-2. However, they could not observe any reduction in viral titers after 5 minutes of exposure to saliva. This indicates that human saliva alone does not have any intrinsic antiviral activity.
Afterward, they tested whether salivary components can alter the anti-SARS-CoV-2 efficacy of cetylpyridinium chloride. The findings revealed that cetylpyridinium chloride-containing mouthwash is capable of completely inhibiting the virus even in presence of saliva.
Irradiated human saliva has no effect upon the viral titer of SARS-CoV-2 as compared to the water control after incubation with inoculum for 5 minutes. Neat saliva had a ratio of 8 parts water to 1-part irradiated human saliva to 1-part virus inoculum, while dilute saliva had a ratio 9 parts irradiated human saliva to 1-part virus inoculum (A). Human saliva does not inhibit the antiviral activity of mouthwash formulas proven to reduce the titer of SARS-CoV-2 (B). MW-B was able to reduce viral titer to below the LODboth in the presence of irradiated human saliva and without. Human saliva was added in a ratio of 8 parts MW-B to 1-part irradiated human saliva to 1-part virus inoculum. Limit of detection (LOD) (2.0log10 PFU/mL) is shown across both graphs with a dotted red line. Error bars represent standard deviation, while red dots are experimental data values and blue dots control values.
The study highlights the potential of cetylpyridinium chloride-containing mouthwashes in inhibiting SARS-CoV-2 and its variants. Regular use of such low-cost mouthwashes as a good oral hygiene practice could potentially reduce the risk of viral transmission to others, as well as through the respiratory tract of an infected person.
Anti-SARS-CoV-2 effectiveness of cetylpyridinium chloride-containing mouthwashes has also been reported in other studies. In addition, human clinical trials are reporting that rinsing the oral cavity with cetylpyridinium chloride-containing mouthwash can effectively reduce the amount of SARS-CoV-2 in saliva for several hours.
Some recent studies have shown that plaque build-up in the oral cavity due to poor hygiene, and subsequent gum infection can increase the risk of viral entry via the oral gingival sulcus and periodontal pockets, leading to respiratory and systemic SARS-CoV-2 infection. Based on the current study findings, such risk can be reduced by regular use of cetylpyridinium chloride-containing mouthwashes.
The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidenceJournal of the Formosan Medical Association:
Background: The COVID-19 pandemic, caused by the spread of SARS-CoV-2 infection that is mainly through the airborne transmission, is a worldwide health concern. This review seeks to assess the potential effectiveness of mouthwash in reducing the oropharyngeal load of SARS-CoV-2 based on the available evidence.
Methods: Articles related to mouthwash and COVID-19 in PubMed were electronically searched in July, 2021. After manually excluding articles lacking sufficient scientific evidence or validation processes, those with inaccessible online full text, those that did not test the effectiveness of mouthwash against SARS-CoV-2, and those not written in English, 17 original and 13 review articles were chosen for this review.
Results: The eligible articles revealed that the main virucidal mechanism of mouthwash was via interactions with the viral envelope. Povidone-iodine (PVP-I), cetylpyridinium chloride (CPC), and essential oils with ethanol showed virucidal effects on SARS-CoV-2 in vitro, potentially by interfering with the viral envelope. A few clinical studies demonstrated that PVP-I, CPC, hydrogen peroxide, and chlorhexidine reduced the oropharyngeal load of SARS-CoV-2.
Conclusion: Although the available evidence is limited, mouthwash containing PVP-I or CPC shows potential for reducing the oropharyngeal load of SARS-CoV-2 and thus may present a risk-mitigation strategy for COVID-19 patients.
Post a Comment